| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.2 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |